SCHEMBL5850848

SCHEMBL5850848

Cc1ccc(S(=O)(=O)N(C(=O)[C@@H]2CCCN2)[C@@](C)(Cc2ccc(OC(=O)N3CCN(C)CC3)cc2)C(=O)OC(C)(C)C)cc1

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPY2R P49146 2/20 0.35
ALDH1A1 P00352 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
TP53 P04637 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
BMP1 P13497 1/20 0.34
STAT3 P40763 1/20 0.33
P2RX7 Q99572 2/20 0.33
GPR119 Q8TDV5 3/20 0.33
MMP13 P45452 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5850647 0.92 CYP1A2 (0.43) L3MBTL1MEN1KMT2ANPY2RALDH1A1
SCHEMBL5852564 0.92 NPY2R (0.38) L3MBTL1MEN1KMT2ANPY2RALDH1A1
SCHEMBL5852329 0.86 PTGES (0.33) MEN1KMT2AALDH1A1STAT3
SCHEMBL5852560 0.84 CYP2C9 (0.45) L3MBTL1MEN1KMT2ANPY2RALDH1A1
SCHEMBL5850614 0.83 PTGES (0.31) STAT3
SCHEMBL5851162 0.83 CYP2C9 (0.41) L3MBTL1MEN1KMT2ANPY2RALDH1A1
SCHEMBL5850810 0.81 DPP4 (0.35) L3MBTL1ALDH1A1NPSR1TP53ALOX15
SCHEMBL5850597 0.80 CYP2D6 (0.36) GPR119
SCHEMBL5852118 0.80 PSEN1 (0.35) MEN1KMT2AALDH1A1
SCHEMBL7461353 0.78 P2RX7 (0.37) L3MBTL1MEN1KMT2ANPY2RALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030114-B1 Compounds which inhibit leukocyte adhesion mediated by VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2006-04-18 US claimed
US-7030114-B1 Compounds which inhibit leukocyte adhesion mediated by VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2006-04-18 US disclosed